MedEquities Realty Trust (MRT) Updates FY 2018 Earnings Guidance

MedEquities Realty Trust (NYSE:MRT) issued an update on its FY 2018 earnings guidance on Friday morning. The company provided earnings per share guidance of $1.00-1.02 for the period.

MRT traded up $0.11 during trading on Friday, hitting $8.73. The stock had a trading volume of 170,074 shares, compared to its average volume of 151,267. The company has a market cap of $270.51 million, a price-to-earnings ratio of 7.66 and a beta of 0.65. MedEquities Realty Trust has a twelve month low of $8.25 and a twelve month high of $12.00.

MedEquities Realty Trust (NYSE:MRT) last announced its earnings results on Wednesday, August 8th. The financial services provider reported $0.10 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.30 by ($0.20). The firm had revenue of $17.56 million during the quarter, compared to analyst estimates of $17.03 million. MedEquities Realty Trust had a net margin of 30.84% and a return on equity of 5.73%. As a group, research analysts anticipate that MedEquities Realty Trust will post 1.08 earnings per share for the current fiscal year.

MRT has been the subject of a number of research analyst reports. B. Riley set a $12.00 price target on shares of MedEquities Realty Trust and gave the stock a buy rating in a report on Thursday, August 9th. Zacks Investment Research raised shares of MedEquities Realty Trust from a hold rating to a buy rating and set a $13.00 price target for the company in a report on Wednesday, July 25th. JMP Securities set a $12.00 price target on shares of MedEquities Realty Trust and gave the stock a buy rating in a report on Tuesday, October 23rd. KeyCorp cut shares of MedEquities Realty Trust from an overweight rating to a hold rating and set a $12.00 price target for the company. in a report on Wednesday, August 8th. Finally, Royal Bank of Canada set a $10.00 price target on shares of MedEquities Realty Trust and gave the stock a hold rating in a report on Sunday, August 12th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and three have given a buy rating to the company. The stock currently has an average rating of Hold and a consensus target price of $11.25.

In related news, Director Bluemountain Capital Managemen sold 3,955 shares of the firm’s stock in a transaction on Friday, October 5th. The shares were sold at an average price of $9.13, for a total transaction of $36,109.15. The transaction was disclosed in a document filed with the SEC, which is available at this link. In the last 90 days, insiders have sold 197,781 shares of company stock worth $1,718,667. 2.50% of the stock is owned by company insiders.

TRADEMARK VIOLATION NOTICE: “MedEquities Realty Trust (MRT) Updates FY 2018 Earnings Guidance” was first posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this story on another domain, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The legal version of this story can be accessed at https://sportsperspectives.com/2018/11/09/medequities-realty-trust-mrt-updates-fy-2018-earnings-guidance.html.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

See Also: Trading Penny Stocks

Earnings History and Estimates for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply